Literature DB >> 30864521

Therapeutic Potential of Vanillin and its Main Metabolites to Regulate the Inflammatory Response and Oxidative Stress.

Carlos S M Bezerra-Filho1, Joice N Barboza1, Marilia T S Souza2, Peter Sabry3, Nasser S M Ismail4, Damião P de Sousa1.   

Abstract

Many phenolic compounds found in foods and medicinal plants have shown interesting therapeutic potential and have attracted the attention of the pharmaceutical industry as promising pharmacologically active compounds in health promotion and disease prevention. Vanillin is a phenolic aldehyde, widely used as a flavoring agent in the food, pharmaceutical, and cosmetics industries. A variety of pharmacological activities has been attributed to this compound and its main metabolites, vanillic acid and vanillyl alcohol, including their anti-inflammatory ability. The relationship of the anti- inflammatory effects of vanillin, vanillic acid, and vanillyl alcohol and their actions on oxidative stress is well established. Considering that the inflammatory process is related to several pathologies, including new diseases with few therapeutic options, and limited efficiency, the search for effective treatment strategies and discovery of new anti-inflammatory agents capable of modulating inflammation becomes necessary. Therefore, in this review, we discuss the therapeutic potential of vanillin and its main metabolites for the treatment of inflammatory diseases and their actions on redox status. In addition, the molecular docking evaluation of vanillin, its metabolites and isoeugenol were carried out into the phospholipase A2 binding site. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Natural products; anti-inflammatory; antioxidant; vanillic acid; vanillin; vanillyl alcohol.

Mesh:

Substances:

Year:  2019        PMID: 30864521     DOI: 10.2174/1389557519666190312164355

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  6 in total

1.  E-liquids and vanillin flavoring disrupts retinoic acid signaling and causes craniofacial defects in Xenopus embryos.

Authors:  Amanda J G Dickinson; Stephen D Turner; Stacey Wahl; Allyson E Kennedy; Brent H Wyatt; Deborah A Howton
Journal:  Dev Biol       Date:  2021-09-17       Impact factor: 3.582

2.  Toxicology of paraquat and pharmacology of the protective effect of 5-hydroxy-1-methylhydantoin on lung injury caused by paraquat based on metabolomics.

Authors:  Lina Gao; Huiya Yuan; Enyu Xu; Junting Liu
Journal:  Sci Rep       Date:  2020-02-04       Impact factor: 4.379

3.  Key Phytochemicals and Biological Functions of Chuanxiong Rhizoma Against Ischemic Stroke: A Network Pharmacology and Experimental Assessment.

Authors:  Peng Zeng; Yao Yi; Hong-Fei Su; Chao-Yuan Ye; Yi-Wen Sun; Xin-Wen Zhou; Youming Lu; Anbing Shi; Qing Tian
Journal:  Front Pharmacol       Date:  2021-12-21       Impact factor: 5.810

4.  Vanillin Activates Human Bitter Taste Receptors TAS2R14, TAS2R20, and TAS2R39.

Authors:  Gabriella Morini; Marcel Winnig; Timo Vennegeerts; Gigliola Borgonovo; Angela Bassoli
Journal:  Front Nutr       Date:  2021-07-09

5.  Vanillin Prevents Doxorubicin-Induced Apoptosis and Oxidative Stress in Rat H9c2 Cardiomyocytes.

Authors:  Ivana Sirangelo; Luigi Sapio; Angela Ragone; Silvio Naviglio; Clara Iannuzzi; Daniela Barone; Antonio Giordano; Margherita Borriello
Journal:  Nutrients       Date:  2020-08-01       Impact factor: 5.717

Review 6.  Natural products can be used in therapeutic management of COVID-19: Probable mechanistic insights.

Authors:  Sabeeha Ali; Manzar Alam; Fatima Khatoon; Urooj Fatima; Abdelbaset Mohamed Elasbali; Mohd Adnan; Asimul Islam; Md Imtaiyaz Hassan; Mejdi Snoussi; Vincenzo De Feo
Journal:  Biomed Pharmacother       Date:  2022-01-20       Impact factor: 6.529

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.